This compound was also examined for mu-opioid receptor activity, and like conolidine, was found to possess no action at the internet site. Making use of the same paw injection exam, quite a few options with larger efficacy were being observed that inhibited the First pain response, indicating opiate

Szpakowska et al. also researched conolidone and its motion about the ACKR3 receptor, which helps to clarify its previously mysterious mechanism of action in each acute and Persistent pain Management (fifty eight). It had been found that receptor amounts of ACKR3 had been as superior as well as grea